Britain tries to cool AstraZeneca concerns as its CEO touts a new vaccine trial

Britain has asked its medicine regulator to assess the vaccine for a temporary supply, which could mean it's rolled out in the country before the end of the year.

from Health and Science https://ift.tt/3qdx74X
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH